8-K
filed June 9, 2023, 7:59 PM ET
ticker CLOV
CIK 0001801170
other
confidence high
sentiment neutral
materiality 0.10
Clover Health shareholders elect directors, approve say-on-pay and auditor ratification at 2023 annual meeting
CLOVER HEALTH INVESTMENTS, CORP. /DE
- Directors Demetrios L. Kouzoukas and Andrew Toy elected with ~937M and ~939M votes for, respectively; 123M broker non-votes.
- Say-on-pay proposal approved: 938.8M for, 15.4M against, 1.4M abstain; broker non-votes 123M.
- Ratification of Ernst & Young as FY2023 auditor passed: 1.07B for, 3.3M against, 1.7M abstain.
- All three proposals passed with strong majority support; no contested matters.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
CLOVER HEALTH INVESTMENTS, CORP. /DE shareholders approved Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2022 at the 2023-06-07 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-06-07
Exact text from the filing
Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2022: The stockholders vote to approve, on a non-binding advisory basis, the compensation of the Company's Named Executive Officers for 2022. The results of the vote were as follows: For Against Abstain Broker Non-Votes 938,847,123 15,400,898 1,440,947 123,427,586
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
CLOVER HEALTH INVESTMENTS, CORP. /DE shareholders approved Election of 2 Class II directors at the 2023-06-07 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-07
Exact text from the filing
The results of the election were as follows: Nominee For Withheld Broker Non-Votes Demetrios L Kouzoukas 937,464,810 18,224,158 123,427,586 Andrew Toy 939,487,709 16,201,259 123,427,586
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
CLOVER HEALTH INVESTMENTS, CORP. /DE shareholders approved Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-07 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-07
Exact text from the filing
Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2023. The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The results of the vote were as follows: For Against Abstain 1,074,118,616 3,280,363 1,717,575
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.